The DOI matches its Crossref record, with a small difference in title or year; 150 of the 155 references it cites were found in a registry or an index.
Macrophage Responses to Hypoxia
Open accessAbstract
The presence of multiple areas of hypoxia (low oxygen tension) is a hallmark feature of human and experimental tumors. Monocytes are continually recruited into tumors, differentiate into tumor-associated macrophages (TAMs), and then accumulate in these hypoxic areas. A number of recent studies have shown that macrophages respond to the levels of hypoxia found in tumors by up-regulating such transcription factors as hypoxia-inducible factors 1 and 2, which in turn activate a broad array of mitogenic, pro-invasive, pro-angiogenic, and pro-metastatic genes. This could explain why high numbers of TAMs correlate with poor prognosis in various forms of cancer. In this review, we assess the evidence for hypoxia activating a distinct, pro-tumor phenotype in macrophages and the possible effect of this on the growth, invasion, angiogenesis, and immune evasion of tumors. We also discuss current attempts to selectively target TAMs for destruction or to use them to deliver gene therapy specifically to hypoxic tumor sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Macrophages accumulate in hypoxic environments to release prohealing and pro-angiogenic factors such as vascular endothelial growth factor (VEGF), platelet derived growth factor (PDGF) [63] and enzymes such as Cyclooxygenase 2 (COX2) [64].”
From Biomaterial based modulation of macrophage polarization: a review and suggested design principles (2015) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
HIF-1α is essential for myeloid cell-mediated inflammation
Cramer, T., Yamanishi, Y., Clausen, B. E., Förster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00154-5 · Cited by 2,046
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Self-citationDer, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,840
Semenza, G. L., Jiang, B.-H., Leung, S. W., Passantino, R., Concordet, J.-P., Maire, P., & Giallongo, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32529 · Cited by 1,752
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
Tonnesen, M. G., Feng, X., & Clark, R. A. F. (2000) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2000.00014.x · Cited by 1,463
Barleon, B., Sozzani, S., Zhou, D., Weich, H., Mantovani, A., & Marmé, D. (1996) · Blood · doi:10.1182/blood.v87.8.3336.bloodjournal8783336 · Cited by 1,350
Research works printed but not linked: 2
- Burton, 2000, Macrophages accumulate in avascular, hypoxic areas of prostate tumors: implications for the targeted therapeutic gene delivery to such sites, J Pathol, 192, 8A
- Ohno, 2004, Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer, Anticancer Res, 24, 3335
Cited by
Sorted by citations
Items 101–200 of 412
Leblond, M. M., Gérault, A. N., Corroyer‐Dulmont, A., MacKenzie, E. T., Petit, E., Bernaudin, M., & Valable, S. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1056442 · Cited by 113
Неганова, М. Е., Liu, J., Aleksandrova, Y. R., Klochkov, S. G., & Fan, R. (2021) · Cancers · doi:10.3390/cancers13236062 · Cited by 112
Ke, X., Chen, C., Song, Y., Cai, Q., Li, J., Tang, Y., Han, X., Qu, W., Chen, A., Wang, H., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.10956 · Cited by 105
Weibel, S., Stritzker, J., Eck, M., Goebel, W., & Szalay, A. A. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01122.x · Cited by 103
Rabbani, Z. N., Spasojević, I., Zhang, X., Moeller, B. J., Haberle, S., Vasquez-Vivar, J. M., Dewhirst, M. W., Vujašković, Ž., & Batinic̈‐Haberle, I. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.07.001 · Cited by 103
Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment
Mahlbacher, G. E., Curtis, L. T., Lowengrub, J. S., & Frieboes, H. B. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0313-7 · Cited by 105
A Nitric Oxide (NO) Nanoreporter for Noninvasive Real‐Time Imaging of Macrophage Immunotherapy
Ramesh, A., Kumar, S., Brouillard, A., Nandi, D., & Kulkarni, A. A. (2020) · Advanced Materials · doi:10.1002/adma.202000648 · Cited by 100
Liu, S.-Y., Chang, L., Pan, L.-F., Hung, Y.-J., Lee, C.-H., & Shieh, Y. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.02.007 · Cited by 100
Hypoxia-mediated regulation of macrophage functions in pathophysiology
Riboldi, E., Porta, C., Morlacchi, S., Viola, A., Mantovani, A., & Sica, A. (2012) · International Immunology · doi:10.1093/intimm/dxs110 · Cited by 95
Yin, J., Oh, Y. T., Kim, J., Kim, S. S., Choi, E., Kim, T. H., Hong, J. H., Chang, N., Cho, H. J., Sa, J. K., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0388 · Cited by 96
Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs)
Sica, A., Porta, C., Morlacchi, S., Banfi, S., Strauss, L., Rimoldi, M., Totaro, M. G., & Riboldi, E. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0091-6 · Cited by 96
Shen, H., Yu, X., Yang, F., Zhang, Z., Shen, J., Sun, J., Choksi, S., Jitkaew, S., & Shu, Y. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006244 · Cited by 91
Xu, L., Cochran, D., Tong, R. T., Winkler, F., Kashiwagi, S., Jain, R. K., & Fukumura, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-3085 · Cited by 89
Xu, H., Zhang, Y., Peña, M. M. O., Pirisi, L. A., & Creek, K. E. (2017) · Carcinogenesis · doi:10.1093/carcin/bgw121 · Cited by 88
Recent advances in anti-angiogenic nanomedicines for cancer therapy
Bhattarai, P., Hameed, S., & Dai, Z. (2018) · Nanoscale · doi:10.1039/c7nr09612g · Cited by 90
Miar, A., Arnaiz, E., Bridges, E., Beedie, S., Cribbs, A. P., Downes, D. J., Beagrie, R., Rehwinkel, J., & Harris, A. L. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2306 · Cited by 86
Chai, C.-Y., Chen, W.-T., Hung, W., Kang, W., Huang, Y.-C., Su, Y., & Yang, C.-H. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.050666 · Cited by 87
Tie2-expressing monocytes (TEMs): Novel targets and vehicles of anticancer therapy?
Palma, M. D., & Naldini, L. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.04.001 · Cited by 88
MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma
Liu, Y.-S., Lin, H.-Y., Lai, S.-W., Huang, C.-Y., Huang, B.-R., Chen, P.-Y., Wei, K.-C., & Lu, D.-Y. (2017) · Oncogene · doi:10.1038/onc.2017.129 · Cited by 85
Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors
Cheever, A., Townsend, M. H., & O'Neill, K. L. (2022) · Cells · doi:10.3390/cells11223626 · Cited by 94
Tumor Associated Macrophages and TAMs‐Based Anti‐Tumor Nanomedicines
Cheng, Y., Song, S., Wu, P., Lyu, B., Qin, M., Sun, Y., Sun, A., Mu, L.-M., Xu, F., Zhang, L., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100590 · Cited by 80
Tumor-Associated Macrophage: Its Role in Cancer Invasion and Metastasis
Shih, J.-Y., Yuan, A., Chen, J. J., & Yang, P. (2006) · doi:10.29685/jcm.200606.0001 · Cited by 80
Kariya, T., Nishimura, H., Mizuno, M., Suzuki, Y., Matsukawa, Y., Sakata, F., Maruyama, S., Takei, Y., & Ito, Y. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00052.2017 · Cited by 81
Characterization and Regulation of Bv8 in Human Blood Cells
Zhong, C., Qu, X., Tan, M., Meng, Y. G., & Ferrara, N. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1954 · Cited by 78
Silva, V. L., & Al-Jamal, W. T. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.013 · Cited by 77
Toll-like Receptor 4 Signaling Promotes Tumor Growth
Lee, C., Wu, C., & Shiau, A. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181b7a0a4 · Cited by 78
The prognostic impact of M‐CSF, CSF‐1 receptor, CD68 and CD3 in prostatic carcinoma
Richardsen, E. H., Uglehus, R. D., Due, J., Busch, C., & Busund, L.-T. R. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03058.x · Cited by 77
Leptin signalling system as a target for pulmonary arterial hypertension therapy
Huertas, A., Tu, L., Thuillet, R., Hiress, M. L., Phan, C., Ricard, N., Nadaud, S., Fadel, É., Humbert, M. J. C., & Guignabert, C. (2015) · European Respiratory Journal · doi:10.1183/09031936.00193014 · Cited by 74
The Role of tumor-associated macrophage in tumor progression
Watabe, K. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s299 · Cited by 75
Tevis, K. M., Cecchi, R. J., Colson, Y. L., & Grinstaff, M. W. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.12.037 · Cited by 74
Current Development of Nano-Drug Delivery to Target Macrophages
Cai, D., Gao, W., Li, Z., Zhang, Y., Xiao, L., & Xiao, Y. (2022) · Biomedicines · doi:10.3390/biomedicines10051203 · Cited by 74
O’Brien, J., & Schedin, P. S. (2009) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-009-9118-8 · Cited by 73
The mechanisms tumor cells utilize to evade the host's immune system
Kuol, N., Stojanovska, L., Nurgali, K., & Apostolopoulos, V. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.04.014 · Cited by 73
Immune cell infiltration of primary and metastatic lesions: Mechanisms and clinical impact
Talmadge, J. E. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.12.002 · Cited by 74
Co‐opting biology to deliver drugs
Yousefpour, P., & Chilkoti, A. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25307 · Cited by 71
Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis
Mazzone, M., & Bergers, G. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114721 · Cited by 70
Seyfried, T. N., Marsh, J., Shelton, L. M., Huysentruyt, L. C., & Mukherjee, P. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.06.017 · Cited by 71
Effects of hypoxia on transcription factor expression in human monocytes and macrophages
Elbarghati, L., Murdoch, C., & Lewis, C. E. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.07.016 · Cited by 70
Self-citationMyeloid cell trafficking and tumor angiogenesis
Schmid, M. C., & Varner, J. A. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.09.002 · Cited by 71
Porta, C., Sica, A., & Riboldi, E. (2017) · FEBS Journal · doi:10.1111/febs.14288 · Cited by 70
Lee, C.-C., Liu, K.-J., Wu, Y.-C., Lin, S.-J., Chang, C.-C., & Huang, T. (2010) · Inflammation · doi:10.1007/s10753-010-9226-z · Cited by 69
Prognostic value of innate and adaptive immunity in colorectal cancer
Grizzi, F. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i2.174 · Cited by 67
Lin, M., Kuo, I., Chang, C.-C., Chu, C., Chen, H., Lin, B., Sureshbabu, M., Shih, H.-J., & Kuo, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708933200 · Cited by 67
RetractedZheng, Y., Yang, W., Aldape, K., He, J., & Lu, Z. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.499020 · Cited by 74
Lewis, C. E., & Hughes, R. (2007) · Breast Cancer Research · doi:10.1186/bcr1679 · Cited by 67
Self-citationHypoxia: a double-edged sword of immunity
Sica, A., Melillo, G., & Varesio, L. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0724-8 · Cited by 66
Cell-Based Drug Delivery Systems with Innate Homing Capability as a Novel Nanocarrier Platform
Choi, A., Javius-Jones, K., Hong, S., & Park, H. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s394389 · Cited by 67
Prediction of individual response to anticancer therapy: historical and future perspectives
Unger, F. T., Witte, I., & David, K. A. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1772-3 · Cited by 71
Hutter, R., Speidl, W. S., Valdiviezo, C., Sauter, B. V., Corti, R., Fuster, V., & Badimón, J. J. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9469-9 · Cited by 67
CAR T Cell Locomotion in Solid Tumor Microenvironment
Nguyen, D., Ogando‐Rivas, E., Liu, R., Wang, T., Rubin, J. A., Jin, L., Tao, H., Sawyer, W. W., Méndez‐Gómez, H. R., Cascio, M., et al. (2022) · Cells · doi:10.3390/cells11121974 · Cited by 65
Guédez, L., Jensen-Taubman, S., Bourboulia, D., Kwityn, C., Wei, B., Caterina, J. J., & Stetler‐Stevenson, W. G. (2012) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182619c8e · Cited by 64
Tumor-associated macrophage infiltration in meningioma
Proctor, D. T., Huang, J. J., Lama, S., Albakr, A. A., van Marle, G., & Sutherland, G. R. (2019) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdz018 · Cited by 63
Mayer, A., & Vaupel, P. W. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-7411-1_28 · Cited by 65
Galmbacher, K., Heisig, M., Hotz, C., Wischhusen, J., Galmiche, A., Bergmann, B., Gentschev, I., Goebel, W., Rapp, U. R., & Fensterle, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009572 · Cited by 66
Mi, Z., Rapisarda, A., Taylor, L. S., Brooks, A., Creighton-Gutteridge, M., Melillo, G., & Varesio, L. (2008) · Cell Cycle · doi:10.4161/cc.7.2.5193 · Cited by 63
Hypoxia-inducible factors as key regulators of tumor inflammation
Mamlouk, S., & Wielockx, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.27901 · Cited by 61
Hypothesis: Are Neoplastic Macrophages/Microglia Present in Glioblastoma Multiforme?
Huysentruyt, L. C., Akgoc, Z., & Seyfried, T. N. (2011) · ASN NEURO · doi:10.1042/an20110011 · Cited by 61
Mammary Gland Macrophages: Pleiotropic Functions in Mammary Development
Schwertfeger, K. L., Rosen, J. M., & Cohen, D. A. (2006) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-006-9028-y · Cited by 62
Tumor-associated macrophages in thoracic malignancies
Lievense, L. A., Bezemer, K., Aerts, J. G. J. V., & Hegmans, J. P. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.02.017 · Cited by 60
Activated macrophages in the tumour microenvironment—dancing to the tune of TLR and NF‐κB
Hallam, S. L., Escorcio‐Correia, M., Soper, R., Schultheiss, A., & Hagemann, T. (2009) · The Journal of Pathology · doi:10.1002/path.2602 · Cited by 62
van der Bilt, J. D. W., Soeters, M. E., Duyverman, A. M. M. J., Nijkamp, M. W., Witteveen, P. O., van Diest, P. J., Kranenburg, O., & Rinkes, I. H. M. B. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061028 · Cited by 59
Jamieson, S. M. F., Tsai, P., Kondratyev, M. K., Budhani, P., Liu, A. J., Senzer, N. N., Chiorean, E. G., Jalal, S. I., Nemunaitis, J. J., Kee, D., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.122204 · Cited by 56
Macrophage colony-stimulating factor and cancer: a review
Chockalingam, S., & Ghosh, S. S. (2014) · Tumor Biology · doi:10.1007/s13277-014-2627-0 · Cited by 58
Riabov, V., Yin, S., Song, B., Avdic, A., Schledzewski, K., Ovsiy, I., Gratchev, A. N., Verdiell, M. L., Sticht, C., Schmuttermaier, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8857 · Cited by 57
Ramaiah, M. J., Naushad, S. M., Ponnusamy, L., Arivazhagan, G., Sakthiprasad, V., & Pal‐Bhadra, M. (2017) · Gene · doi:10.1016/j.gene.2017.10.018 · Cited by 59
Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma
Alexandrakis, M. G., Goulidaki, N., Pappa, C. A., Boula, A., Psarakis, F. E., Neonakis, I., & Tsirakis, G. (2015) · Pathology & Oncology Research · doi:10.1007/s12253-015-9921-z · Cited by 56
Biogenic gold nanoparticles: As a potential candidate for brain tumor directed drug delivery
Tripathi, R. M., Shrivastav, A., & Shrivastav, B. R. (2014) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.885445 · Cited by 58
Wu, F., Yang, S., Tang, X., Liu, W., Chen, H., & Gao, H. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13330 · Cited by 56
Intravenous clusterin administration reduces myocardial infarct size in rats
van Dijk, A., Vermond, R. A., Krijnen, P. A. J., Juffermans, L. J. M., Hahn, N. E., Makker, S. P., Aarden, L. A., Hack, E., Spreeuwenberg, M. D., van Rossum, B. C., et al. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02345.x · Cited by 60
Perspectives on the mesenchymal origin of metastatic cancer
Huysentruyt, L. C., & Seyfried, T. N. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9254-z · Cited by 55
The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer
Metin, C. U., & Özcan, G. (2022) · Cancers · doi:10.3390/cancers14112711 · Cited by 56
Massi, D., Marconi, C., Franchi, A., Bianchini, F., Paglierani, M., Ketabchi, S., Miracco, C., Santucci, M., & Calorini, L. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.02.018 · Cited by 53
Effects of Radiation Therapy on Neural Stem Cells
Michaelidesova, A. J., Konířová, J., Bartůněk, P., & Zı́ková, M. (2019) · Genes · doi:10.3390/genes10090640 · Cited by 55
Placental Hypoxia during Placental Malaria
Boeuf, P., Tan, A., Romagosa, C., Radford, J., Mwapasa, V., Molyneux, M. E., Meshnick, S. R., Hunt, N. H., & Rogerson, S. J. (2008) · The Journal of Infectious Diseases · doi:10.1086/526521 · Cited by 50
Staples, K. J., Sotoodehnejadnematalahi, F., Pearson, H. B., Frankenberger, M., Francescut, L., Ziegler‐Heitbrock, L., & Burke, B. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.12.005 · Cited by 50
Wang, Y., Ma, Y.-Y., Song, X.-L., Cai, H., Chen, J., Song, L., Yang, R., & Lu, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002958 · Cited by 52
Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk
Morandi, A., Giannoni, E., & Chiarugi, P. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.11.001 · Cited by 50
Herbert, A., Ng, H., Jessup, W., Kockx, M., Cartland, S. P., Thomas, S. R., Hogg, P. J., & Wargon, O. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10086.x · Cited by 50
Dynamic Education of Macrophages in Different Areas of Human Tumors
Wu, Y., & Zheng, L. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0113-z · Cited by 51
Wang, J., Liu, M., Wu, Q., Li, Q., Gao, L., Jiang, Y. Y., Deng, B., Huang, W. C., Bi, W., Chen, Z., et al. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7688 · Cited by 50
Seyfried, T. N., Shelton, L. M., Arismendi-Morillo, G., Kalamian, M., Elsakka, A. M., Maroon, J. C., & Mukherjee, P. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02795-4 · Cited by 50
Mutually Supportive Mechanisms of Inflammation and Vascular Remodeling
Whiteford, J. R., Rossi, G. D., & Woodfin, A. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.05.001 · Cited by 48
Tumor-specific macrophage targeting through recognition of retinoid X receptor beta
Tang, T., Wei, Y., Kang, J., She, Z., Kim, D., Sailor, M. J., Ruoslahti, E. I., & Pang, H. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.009 · Cited by 47
Emerging methods in therapeutics using multifunctional nanoparticles
Habibi, N., Quevedo, D. F., Gregory, J. V., & Lahann, J. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1625 · Cited by 48
Tumor Immuno-Environment in Cancer Progression and Therapy
Kaliński, P., & Talmadge, J. E. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_1 · Cited by 49
Ciucci, A., Zannoni, G. F., Buttarelli, M., Lisi, L., Travaglia, D., Martinelli, E., Scambia, G., & Gallo, D. (2016) · Oncotarget · doi:10.18632/oncotarget.6943 · Cited by 46
The tumour microenvironment and implications for cancer immunotherapy
Petrulio, C., Kim‐Schulze, S., & Kaufman, H. L. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.7.671 · Cited by 45
Campillo, N., Torres, M., Vilaseca, A., Nonaka, P. N., Gozal, D., Roca‐Ferrer, J., Picado, C., Montserrat, J. M., Farré, R., Navajas, D., et al. (2017) · Scientific Reports · doi:10.1038/srep44693 · Cited by 50
Zheng, B., Yang, B., Chen, H., Pan, H., Ji, W., Gong, X., Wu, X., Wang, H., & Chang, J. K. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b05706 · Cited by 45
Hu, B., Yang, X., & Sang, X. (2020) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s272109 · Cited by 46
Modification of the tumor microenvironment to enhance immunity
Liao, Y. (2007) · Frontiers in bioscience · doi:10.2741/2336 · Cited by 44
Physical plasma and leukocytes – immune or reactive?
Bekeschus, S., Seebauer, C., Wende, K., & Schmidt, A. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0224 · Cited by 45
Leonard, F., Curtis, L. T., Hamed, A. R., Zhang, C., Chau, E. P., Sieving, D., Godin, B., & Frieboes, H. B. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02504-z · Cited by 44
Degrossoli, A., Bosetto, M. C., Lima, C. B. C., & Giorgio, S. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.09.009 · Cited by 44
Misfolded human tRNA isodecoder binds and neutralizes a 3′ UTR-embedded Alu element
Rudinger‐Thirion, J., Lescure, A., Paulus, C., & Frugier, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103698108 · Cited by 48
Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
Ewendt, F., Feger, M., & Föller, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.601006 · Cited by 43
Macrophage-Based Anti-Cancer Therapy: Modelling Different Modes of Tumour Targeting
Webb, S. D., Owen, M. R., Byrne, H. M., Murdoch, C., & Lewis, C. E. (2007) · Bulletin of Mathematical Biology · doi:10.1007/s11538-006-9189-2 · Cited by 43
Self-citationAlizadeh, N., Pepper, M. S., Modarressi, A., Alfo, K., Schlaudraff, K.-U., Montandon, D., Gabbiani, G., Bochaton‐Piallat, M., & Pittet, B. (2007) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00312.x · Cited by 43
Bourdel, N., Matsuzaki, S., Bazin, J.-É., Pouly, J. L., Mage, G., & Canis, M. J. (2007) · Human Reproduction · doi:10.1093/humrep/del482 · Cited by 43
S‐nitrosylation of caspase‐3 is the mechanism by which adhesion fibroblasts manifest lower apoptosis
Jiang, Z., Fletcher, N. M., Diamond, M. P., Abu‐Soud, H. M., & Saed, G. M. (2009) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2009.00459.x · Cited by 42
Metadata
- Authors
- Lewis, C., & Murdoch, C.
- Affiliations
- University of Sheffield (GB)
- Corresponding author
- Lewis, Claire
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 167
- Issue
- 3
- Pages
- 627-635
- ISSN
- 0002-9440 (ISSN-L)
- PMC
- PMC1698733
- OpenAlex
- W1515730558
- Cited by
- 413
- References
- 155
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 12 · 2023: 16 · 2022: 15 · 2021: 16 · 2020: 19 · 2019: 21 · 2018: 13 · 2017: 25 · 2016: 19 · 2015: 17 · 2014: 26 · 2013: 20 · 2012: 27
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal Of Pathology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- School of Medicine, University of North Carolina at Chapel Hill
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumor-associated macrophages, hypoxia, HIF-1, HIF-2, tumor microenvironment, tumor invasion, tumor angiogenesis, metastasis, immune evasion, macrophage polarization, TAM-targeted therapy
- MeSH terms
- Animals, Hypoxia, Humans, Macrophages, Neoplasms, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review